SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC 20549

                             _____________________

                                 SCHEDULE 13D
                                (Rule 13d-101)

            INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
                 TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED
                           PURSUANT TO RULE 13d-2(a)



                          OraSure Technologies, Inc.
- -------------------------------------------------------------------------------
                               (Name of Issuer)

                  Common Stock, par value $.000001 per share
- -------------------------------------------------------------------------------
                        (Title of Class of Securities)

                                  68554V 10 8
                                  -----------
                                (CUSIP Number)

                              Michael J. Gausling
                          OraSure Technologies, Inc.
                              150 Webster Street
                         Bethlehem, Pennsylvania 18015
                                (610) 882-1820
- -------------------------------------------------------------------------------
 (Name, Address and Telephone Number of Person Authorized to Receive Notices
                              and Communications)

                              September 29, 2000
- -------------------------------------------------------------------------------
            (Date of Event Which Requires Filing of this Statement)


     If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box.  [_]

     Note:  Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7 for other
parties to whom copies are to be sent.

                      (Continued on the following pages)

                               Page 1 of 6 Pages

________________
/1/  The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be filed for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


- -----------------------                                  ----------------------
CUSIP No. 68554V 10 8                                    Page 2 of 6 Pages
- -----------------------                                  ----------------------


- -------------------------------------------------------------------------------
1.
          NAMES OF REPORTING PERSONS
          I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

          Michael J. Gausling
- -------------------------------------------------------------------------------
2.
          CHECK THE APPROPRIATE BOX IF A GROUP*                         (a) [_]
                                                                        (b) [X]

- -------------------------------------------------------------------------------
3.
          SEC USE ONLY

- -------------------------------------------------------------------------------
4.
          SOURCE OF FUNDS


          OO
- -------------------------------------------------------------------------------
5.
          CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
          ITEM 2(d) OR 2(e)

- -------------------------------------------------------------------------------
6.
          CITIZENSHIP OR PLACE OF ORGANIZATION

          United States of America
- -------------------------------------------------------------------------------
    NUMBER OF       7.
      SHARES              SOLE VOTING POWER
                                                       2,080,419
                    -----------------------------------------------------------
   BENEFICIALLY     8.
     OWNED BY             SHARED VOTING POWER          34,424
                    -----------------------------------------------------------
       EACH         9.
    REPORTING             SOLE DISPOSITIVE POWER       2,080,419
                    -----------------------------------------------------------
   PERSON WITH      10.
                          SHARED DISPOSTIVE POWER      34,424
- -------------------------------------------------------------------------------
11.
          AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                                                                    2,114,843
- -------------------------------------------------------------------------------
12.
          CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
          SHARES *

- -------------------------------------------------------------------------------
13.
          PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   5.8%
- -------------------------------------------------------------------------------
14.
          TYPE OF REPORTING PERSON*

          IN
- -------------------------------------------------------------------------------
                    * SEE INSTRUCTIONS BEFORE FILLING OUT!


                                                               Page 3 of 6 Pages

Item 1.  Security and Issuer.

         (a)      Title of the Security:

         Common Stock, $.000001 par value per share.

         (b)      Name of the Issuer:

         OraSure Technologies, Inc., a Delaware corporation.

         (c)      The Issuer's address of its principal executive office:

         8505 SW Creekside Place
         Beaverton, Oregon 97008

Item 2.  Identity and Background.

         (a)      Name:

         Michael J. Gausling

         (b)      Business Address:

         150 Webster Street
         Bethlehem, Pennsylvania 18015

         (c)      Present principal occupation and name and address of such
         principal occupation:

         Mr. Gausling is the President and Chief Operating Officer of the Issuer
         at the address listed in Item 2.(b) above.

         (d)      Criminal Convictions within the past five years:

         Mr. Gausling has not been the subject of any criminal proceeding
         resulting in his conviction in the previous five years from the date of
         the statement.

         (e)      Party to a Civil Proceeding in the past five years:

         During the past five years, Mr. Gausling has not been a party to any
         civil proceeding of a judicial or administrative body with said
         proceeding resulting in judgement, decree or final order enjoining
         future violations of, or prohibiting or mandating activities subject
         to, federal or state securities laws or finding any violation with
         respect to such laws.


                                                               Page 4 of 6 Pages

         (f)      Citizenship:

         United States of America.


Item 3.  Source and Amount of Funds or Other Consideration.


As of the date of this statement, Mr. Gausling is the beneficial owner of
529,601 shares of common stock held by a trust of which Mr. Gausling is the sole
trustee. Mr. Gausling is the beneficial owner of 34,424 shares of common stock
held by a trust of which Mr. Gausling's wife is the co-trustee with an
independent third party. In addition, Mr. Gausling is the direct beneficial
owner of 1,550,818 shares of common stock. Mr. Gausling acquired the shares of
Issuer's common stock upon the conversion of shares of common stock of STC
Technologies, Inc. ("STC") into shares of common stock of the Issuer as a result
of a transaction in which each of Epitope, Inc. ("Epitope") and STC merged into
the Issuer (the "Merger") pursuant to an Agreement and Plan of Merger dated May
6, 2000 (the "Agreement"). Prior to the Merger, Epitope's common stock was
listed on the NASDAQ National Market System under the symbol "EPTO" and the
capital stock of STC was privately held and not traded in a public market. Upon
the completion of the Merger, the Issuer assumed Epitope's listing on the NASDAQ
National Market System under the symbol "OSUR" and assumed Epitope's
registration under Section 12(g) of the Securities Exchange Act of 1934, as
amended, as successor to Epitope, pursuant to Rule 12g-3 promulgated thereunder.
Pursuant to the Agreement, shares of Epitope's common stock were converted into
Issuer's common stock on a one-for-one basis and shares of STC's common stock
were converted into Issuer's common stock on a one for 5.2960102794 basis. Upon
the completion of the Merger, 36,340,210 shares of Issuer's common stock were
issued and outstanding.

Item 4.  Purpose of Transaction.


Mr. Gausling's reporting obligation on this statement arose as a result of the
effectiveness of the Merger, described in Item 3. above, on September 29, 2000.
In connection with the Merger and pursuant to the Agreement, the board of
directors of the Issuer consists of seven members of which three were designated
by the board of directors of STC in which Mr. Gausling was designated as a
member of the Issuer's board of directors, three were designated by the board of
directors of Epitope and one was designated by the board of directors of both
STC and Epitope. In addition, the persons who were executive officers of STC,
including Mr. Gausling, are officers of the Issuer.

(a)-(j)  At the time Mr. Gausling acquired such shares, Mr. Gausling did not
have any plan or proposal which related to, or would result in any action with
respect to, the matters listed in paragraphs (b) through (j) of Item 4 of
Schedule 13D (although Mr. Gausling reserves the right as a director and
executive officer of the Issuer to develop such plans or proposals). In the
future,


                                                               Page 5 of 6 Pages

Mr. Gausling may decide to purchase additional shares of common stock in the
open market or private transactions, or to sell any or all of his shares of
common stock.


Item 5.    Interest in Securities of the Issuer.

           (a)      Aggregate Number of Shares Beneficially Owned:

           2,114,843

           Percentage of Securities Beneficially Owned:

           5.8%

           (b)      Mr. Gausling has sole dispositive and voting power over
           2,080,419 shares of common stock reported or beneficially owned by
           Mr. Gausling and shares dispositive and voting power over 34,424
           shares of common stock held by a trust of which Mr. Gausling's wife
           is co-trustee.

           (c)      Not Applicable.

           (d)      Not Applicable.

           (e)      Not Applicable.

Item 6     Contracts, Arrangements, Understandings or Relationships with respect
to Securities of the Issuer.

STC granted Mr. Gausling the right to purchase 3,000 shares of common stock of
STC on December 15, 1999 at an exercise price of $4.25 per share which vest
ratably over a four year period commencing on December 15, 2000 (the "Option").
Upon the completion of Merger, the Issuer converted the Option into a right to
purchase 15,888 shares of Issuer's common stock at an exercise price of $.81 per
share vesting on the same basis as the Option. The shares underlying the Option
are not included in Mr. Gausling's beneficial ownership calculations in this
statement because no shares underlying the Option are currently exercisable or
exercisable within 60 days of the date of this statement.

Item 7.    Material to Be Filed as Exhibits


Exhibit No.      Description of Exhibit

99.1             Agreement and Plan of Merger dated May 6, 2000 (filed as Annex
                 A to the Issuer's Registration Statement on Form S-4 filed on
                 June 14, 2000, as amended and is incorporated herein by
                 reference).


                                                               Page 6 of 6 Pages

                                   SIGNATURE
                                   ---------

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.



Dated: October 10, 2000

                                                    /s/ Michael J. Gausling
                                                    -----------------------
                                                    Michael J. Gausling